BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28494061)

  • 1. Association Between Hospital Volume and 30-Day Readmissions Following Transcatheter Aortic Valve Replacement.
    Khera S; Kolte D; Gupta T; Goldsweig A; Velagapudi P; Kalra A; Tang GHL; Aronow WS; Fonarow GC; Bhatt DL; Aronow HD; Kleiman NS; Reardon M; Gordon PC; Sharaf B; Abbott JD
    JAMA Cardiol; 2017 Jul; 2(7):732-741. PubMed ID: 28494061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short Length of Stay After Elective Transfemoral Transcatheter Aortic Valve Replacement is Not Associated With Increased Early or Late Readmission Risk.
    Sud M; Qui F; Austin PC; Ko DT; Wood D; Czarnecki A; Patel V; Lee DS; Wijeysundera HC
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28438738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedural Volume and Outcomes of Transfemoral Transcatheter Aortic Valve Replacement: From a Japanese Nationwide Registry.
    Ando T; Kumamaru H; Kohsaka S; Fukutomi M; Onishi T; Shimamura K; Hayashida K; Tobaru T
    Am J Cardiol; 2023 Dec; 209():36-41. PubMed ID: 37858593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of a Machine Learning Risk-Prediction Model for 30-Day Readmission for Heart Failure Following Transcatheter Aortic Valve Replacement (TAVR-HF Score).
    Zahid S; Agrawal A; Salman F; Khan MZ; Ullah W; Teebi A; Khan SU; Sulaiman S; Balla S
    Curr Probl Cardiol; 2024 Feb; 49(2):102143. PubMed ID: 37863456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Readmission and In-Hospital Outcomes After Transcatheter Aortic Valve Replacement in Patients With Dementia.
    Park DY; Sana MK; Shoura S; Hammo H; Hu JR; Forrest JK; Lowenstern A; Cleman M; Ahmad Y; Nanna MG
    Cardiovasc Revasc Med; 2023 Jan; 46():70-77. PubMed ID: 35973922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of a statewide payment reform on transcatheter aortic valve replacement (TAVR) utilization and readmissions.
    Yesantharao PS; Etchill EW; Zhou AL; Ong CS; Metkus TS; Canner JK; Alejo DE; Aliu O; Czarny MJ; Hasan RK; Resar JR; Schena S
    Catheter Cardiovasc Interv; 2023 Jun; 101(7):1193-1202. PubMed ID: 37102376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter Aortic Valve Replacement in Patients With or Without Active Cancer.
    Aikawa T; Kuno T; Malik AH; Briasoulis A; Kolte D; Kampaktsis PN; Latib A
    J Am Heart Assoc; 2023 Nov; 12(21):e030072. PubMed ID: 37889175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fully independent external validation of the Transcatheter Aortic Valve Replacement 30-day (TAVR-30) hospital readmission model.
    Nilsson K; Buccheri S; Lindbäck J; Sarno G; James S
    Cardiovasc Revasc Med; 2023 Nov; 56():9-15. PubMed ID: 37331886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes, Timing, Hospital Costs and Perioperative Outcomes of Index vs Nonindex Hospital Readmissions after Radical Cystectomy: Implications for Regionalization of Care.
    Chappidi MR; Kates M; Stimson CJ; Johnson MH; Pierorazio PM; Bivalacqua TJ
    J Urol; 2017 Feb; 197(2):296-301. PubMed ID: 27545575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All-cause procedural readmissions following transcatheter aortic valve replacement.
    Newell P; Javadikasgari H; Rojas-Alexandre M; Hirji S; Harloff M; Cherkasky O; McGurk S; Malarczyk A; Shah P; Sabe A; Kaneko T
    JTCVS Open; 2023 Sep; 15():83-93. PubMed ID: 37808066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Hospital Market Competition on the Adoption of Transcatheter Aortic Valve Replacement.
    Strobel RJ; Likosky DS; Brescia AA; Kim KM; Wu X; Patel HJ; Deeb GM; Thompson MP
    Ann Thorac Surg; 2020 Feb; 109(2):473-479. PubMed ID: 31394089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National experience with pediatric surgical aortic valve repair: A Pediatric Health Information System analysis.
    Kulshrestha K; Greenberg JW; Kennedy JT; Hogue S; Zafar F; Lehenbauer D; Winlaw DS; Quintessenza JA; Morales DLS; Ashfaq A
    J Thorac Cardiovasc Surg; 2024 Feb; 167(2):422-430. PubMed ID: 37385525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter aortic valve implantation with and without mitral stenosis - A national readmission database study.
    Ali S; Thyagaturu H; Atti L; Byreddi LY; Roma N; Duhan S; Farooq F; Keisham B; Awad M; Santer M; Jagadeesan V; Kawsara A; Hamirani YS
    Cardiovasc Revasc Med; 2024 Mar; ():. PubMed ID: 38548532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes for High-Risk Surgical Procedures Across High- and Low-Competition Hospital Markets.
    Thumma SR; Dualeh SHA; Kunnath NJ; Bonner SN; Ibrahim AM
    JAMA Surg; 2023 Oct; 158(10):1041-1048. PubMed ID: 37531126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatology-specific and all-cause 30-day and calendar-year readmissions and costs for dermatologic diseases from 2010 to 2014.
    Zhang M; Markova A; Harp J; Dusza S; Rosenbach M; Kaffenberger BH
    J Am Acad Dermatol; 2019 Sep; 81(3):740-748. PubMed ID: 31102603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Care fragmentation and readmission mortality and length of stay before and during the COVID-19 pandemic: data from the National Readmissions Database, 2018-2020.
    Turbow S; Walker T; Culler S; Ali MK
    BMC Health Serv Res; 2024 May; 24(1):622. PubMed ID: 38741088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ninety-Day Risk-Standardized Home Time as a Performance Metric for Cardiac Surgery Hospitals in the United States.
    Mentias A; Desai MY; Keshvani N; Gillinov AM; Johnston D; Kumbhani DJ; Hirji SA; Sarrazin MV; Saad M; Peterson ED; Mack MJ; Cram P; Girotra S; Kapadia S; Svensson L; Pandey A
    Circulation; 2022 Oct; 146(17):1297-1309. PubMed ID: 36154237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital Readmission and Costs of Total Knee Replacement Surgery in 2009 and 2014: Potential Implications for Health Care Managers.
    Cary MP; Goode V; Crego N; Thornlow D; Colón-Emeric C; van Houtven C; Merwin EI
    Health Care Manag (Frederick); 2019; 38(1):24-28. PubMed ID: 30640242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital Characteristics Associated with Observed Transcatheter Aortic Valve Replacement Prices.
    Ochakovski R; Zhang Y; Cerullo M
    medRxiv; 2024 May; ():. PubMed ID: 38826203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving patient outcomes with a mobile digital health platform for patients undergoing transcatheter aortic valve replacement.
    Venkatraman V; Lad SP; Gellad ZF; Heo H; Wu KA; Dharmapurikar R; Liu B; Jung SH; Plichta R; Harrison JK; Nguyen TC; Doberne J
    J Invasive Cardiol; 2023 Sep; 35(9):. PubMed ID: 37983113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.